Back to Search Start Over

In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y

Authors :
Y. Diana Kwong
Chi-yuan Hsu
Source :
Annals of Internal Medicine. 176:JC26
Publication Year :
2023
Publisher :
American College of Physicians, 2023.

Subjects

Subjects :
Internal Medicine
General Medicine

Details

ISSN :
15393704 and 00034819
Volume :
176
Database :
OpenAIRE
Journal :
Annals of Internal Medicine
Accession number :
edsair.doi...........ddadc427ee264094ff0324fc48970287